4 Results for "

Mutant IDH1-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Mutant IDH1-IN-2" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-18717
CAS No.: 1429176-69-1
Research Areas:  

Cancer

Mutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of in LS-MS biochemical assay, IC50 of 16.6 nM in Fluorescence biochemical assay.
loading...
    loading...
Cat. No.: HY-175213
Research Areas:  

Cancer

Mutant IDH1-IN-7 is a highly selective Isocitrate Dehydrogenase 1 (IDH1) R132H (IC50 = 0.26 μM, Kd = 2.1 μM)/R132C (IC50 = 1.1 μM) inhibitor. Mutant IDH1-IN-7 has no inhibitory effect on wild-type IDH1, IDH2-wt, and IDH2 R140Q. Mutant IDH1-IN-7 inhibits 2-Hydroxyglutarate (2-HG) production in U87-MG R132H cells (EC50 = 0.55 μM). Mutant IDH1-IN-7 exhibits moderate antiproliferative effects on U87-MG R132H and HT-1080 cells .
loading...
    loading...
Cat. No.: HY-121736
CAS No.: 1446501-77-4
Synonyms: AGI-026
Research Areas:  

Neurological Disease

AGI-12026 is brain-penetrant dual inhibitor of mutant IDH1 and 2. AGI-12026 shows partial inhibition of the IDH1-R132H homodimer as allosteric modulators. AGI-12026 has the potential for research of glioma .
loading...
    loading...
Cat. No.: HY-123153
CAS No.: 1816331-64-2
Research Areas:  

Cancer

GSK990 is an inactive mutant IDH1 inhibitor with no significant inhibitory activity against wild-type or mutant IDH1/IDH2 enzymes. In experiments, GSK990 can serve as an inactive negative control for the IDH1 inhibitor GSK321 (HY-18948). GSK990 is applicable to the research of acute myeloid leukemia .
loading...
    loading...